Squamous cell carcinoma of the breast in the United States: incidence, demographics, tumor characteristics, and survival
- PMID: 28432512
- DOI: 10.1007/s10549-017-4251-3
Squamous cell carcinoma of the breast in the United States: incidence, demographics, tumor characteristics, and survival
Abstract
Purpose: Squamous cell carcinoma of breast accounts for less than 0.1% of all breast cancers. The purpose of this study is to describe the epidemiology and survival of this rare malignancy.
Methods: Data were extracted from the National Cancer Institute's Surveillance, Epidemiology and End Results Registry to identify women diagnosed with squamous cell carcinoma of breast between 1998 and 2013. SEER*Stat 8.3.1 was used to calculate age-adjusted incidence, age-wise distribution, and annual percentage change in incidence. Kaplan-Meier curves were plotted for survival analysis. Univariate and multivariate Cox proportional hazard regression model was used to determine predictors of survival.
Results: A total of 445 cases of squamous cell carcinoma of breast were diagnosed during the study period. The median age of diagnosis was 67 years. The overall age-adjusted incidence between 1998 and 2013 was 0.62 per 1,000,000 per year, and the incidence has been on a decline. Approximately half of the tumors were poorly differentiated. Stage II was the most common stage at presentation. Majority of the cases were negative for expression of estrogen and progesterone receptor. One-third of the cases underwent breast conservation surgery while more than half of the cases underwent mastectomy (unilateral or bilateral). Approximately one-third of cases received radiation treatment. The 1-year and 5-year cause-specific survival was 81.6 and 63.5%, respectively. Excluding patient with metastasis or unknown stage at presentation, in multivariate Cox proportional hazard model, older age at diagnosis and higher tumor stage (T3 or T4) or nodal stage at presentation were significant predictors of poor survival.
Conclusions: Our study describes the unique characteristics of squamous cell carcinoma of breast and demonstrates that it is an aggressive tumor with a poor survival. Older age and higher tumor or nodal stages at presentation were independent predictors of poor survival for loco-regional stages.
Keywords: Breast; Epidemiology; SEER; Squamous; Squamous cell carcinoma; Survival.
Similar articles
-
Incidence of and treatment for ductal carcinoma in situ of the breast.JAMA. 1996 Mar 27;275(12):913-8. JAMA. 1996. PMID: 8598618
-
A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.Breast Cancer Res Treat. 2008 Oct;111(3):541-7. doi: 10.1007/s10549-007-9809-z. Epub 2007 Nov 18. Breast Cancer Res Treat. 2008. PMID: 18026874
-
Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.Am J Clin Oncol. 2016 Oct;39(5):458-62. doi: 10.1097/COC.0000000000000078. Am J Clin Oncol. 2016. PMID: 24781343
-
Cancer of the Larynx-20-Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and ICD-O-3 Topographic Primary Sites-Codes C32.0-9: A Systematic Review of 43,103 Cases for Diagnosis Years 1975-2017: (NCI SEER*Stat 8.3.9).J Insur Med. 2024 Jul 1;51(2):92-110. doi: 10.17849/insm-51-2-92-110.1. J Insur Med. 2024. PMID: 39266004
-
20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes: A Systematic Review of 157,258 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).J Insur Med. 2019;48(1):5-23. doi: 10.17849/insm-48-1-1-19.1. Epub 2019 Oct 14. J Insur Med. 2019. PMID: 31609640
Cited by
-
A polymorphism in the lysyl oxidase propeptide domain accelerates carcinogen-induced cancer.Carcinogenesis. 2018 Jul 3;39(7):921-930. doi: 10.1093/carcin/bgy045. Carcinogenesis. 2018. PMID: 29579155 Free PMC article.
-
Squamous cell carcinoma developed in a chronic radiation-induced chest wall ulcer that is difficult to undergo thorough preoperative histological examination.Int J Surg Case Rep. 2020;72:467-470. doi: 10.1016/j.ijscr.2020.05.081. Epub 2020 Jun 17. Int J Surg Case Rep. 2020. PMID: 32698267 Free PMC article.
-
A rare case of HER2-positive pure metaplastic squamous cell carcinoma of the breast.Discov Oncol. 2025 Jul 16;16(1):1340. doi: 10.1007/s12672-025-03107-9. Discov Oncol. 2025. PMID: 40665074 Free PMC article.
-
Breast Squamous Cell Carcinoma Following Breast Augmentation.Cureus. 2018 Oct 3;10(10):e3405. doi: 10.7759/cureus.3405. Cureus. 2018. PMID: 30533339 Free PMC article.
-
Primary squamous cell carcinoma of the breast: a case report.Discov Oncol. 2024 Apr 1;15(1):93. doi: 10.1007/s12672-024-00958-6. Discov Oncol. 2024. PMID: 38558111 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials